An open label, randomized, two-period, two-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of Valacyclovir Oral Suspension compared to Valtrex® Tablets in normal, healthy subjects under fasting conditions.
This study is a research project focusing on a new liquid medicine. It's a type of valacyclovir, a drug used to help treat certain viral infections. We want to find out how quickly and completely this liquid medicine gets into the bloodstream of healthy people when they haven't eaten. To do this, we'll compare it directly with the currently available valacyclovir tablets, known as Valtrex®. This kind of study helps us understand if the new liquid medicine works the same way in the body as the well-known tablets, ensuring it’s absorbed just as effectively. It’s an important step before making new medicines widely available.
At a glance
What is this study about?
This research study is focused on a medicine called valacyclovir, which doctors prescribe to help treat certain viral infections, like cold sores or shingles. This particular study wants to understand a new liquid version of this medicine. When you take a medicine, your body has to absorb it into your bloodstream so it can start working. This study is specially designed to see how well the liquid valacyclovir is absorbed by the body compared to the tablet form (which is known as Valtrex®).
Think of it like this: if you drink a glass of water versus eating an ice cube, both are water, but they get into your body differently. This study is trying to confirm that the liquid valacyclovir gets into your system in a similar way and at a similar speed as the Valtrex® tablets. This is called a 'bioavailability' study, meaning we are looking at how much of the medicine becomes available to your body.
This kind of study is very important. It helps doctors and pharmacists know if different forms of the same medicine (like a liquid versus a tablet) will work just as well for patients. It's an early stage of testing, done with healthy volunteers, to make sure the medicine is absorbed properly before it can be used more widely.
Key takeaways
- Study compares a new liquid valacyclovir to existing tablets.
- Aims to see how well the body absorbs the liquid medicine.
- Only healthy adults (18+) can participate.
- Involves taking both forms of the medicine, with blood samples taken.
- Participation helps future medicine development.
Who may be eligible?
To join this study, you need to be a healthy adult aged 18 years or older. All genders, male and female, are welcome to take part. This study is specifically designed for healthy individuals, not for people who are currently unwell or have ongoing medical conditions.
Because this is an early study exploring how a new form of medicine behaves in the body, it's really important that participants are generally in good health. This helps the researchers understand the medicine's effects clearly, without other health issues getting in the way.
More specific health checks will be done by the study team to make sure it's safe for you to participate and that you meet all the necessary requirements for the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Am I 18 years old or older?
- Do I consider myself to be in good general health?
- Am I able to follow instructions carefully for taking medicine and attending appointments?
- Am I comfortable with having blood samples taken several times?
- Am I able to take medication on an empty stomach when required?
What does participation involve?
If you decide to take part in this study, you would receive both the liquid valacyclovir and the Valtrex® tablets at different times. This is called a 'crossover' study, meaning you'll try each form of the medicine. You will be asked to take the medicine when you haven't eaten anything (fasting conditions).
The study involves several visits to the clinic, where blood samples will be taken at specific times after you take the medicine to measure how much of it is in your bloodstream. There will also be health checks and monitoring for any side effects. You will spend some time at the study clinic for each part of the study, and there will be breaks between receiving the different medicines.
The research team will explain the exact schedule, including how many visits, how long each visit might be, and the total length of your involvement in the study.
Potential risks and benefits
Locations (1)
- —UnverifiedCzechia
Common questions
What is valacyclovir?
Valacyclovir is a medicine used to treat certain viral infections, like cold sores or shingles.
Why is a liquid version of the medicine being studied?
A liquid version might be easier for some people to take, especially those who have trouble swallowing pills. This study helps ensure it works just as well.
Do I have to be sick to join this study?
No, this study is specifically looking for healthy adults. It's not for people who are currently unwell.
What does 'fasting conditions' mean?
It means you will take the medicine when you haven't eaten any food for a certain amount of time, usually overnight. This helps researchers see how the medicine is absorbed without food interfering.
Will I get paid for taking part?
Many studies offer some payment for your time and travel, but you should ask the study team for specific details.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.